Interaction between clopidogrel and proton pump inhibitors.
Friesen
Mark H
MH
D053799:2-Pyridinylmethylsulfinylbenzimidazoles / Q000494:pharmacology; D016022:Case-Control Studies; D000077144:Clopidogrel; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D006801:Humans; D064747:Lansoprazole; D009203:Myocardial Infarction / Q000517:prevention & control*; D016017:Odds Ratio; D009853:Omeprazole / Q000494:pharmacology; D010975:Platelet Aggregation Inhibitors / Q000494:pharmacology*; D054328:Proton Pump Inhibitors / Q000494:pharmacology*; D064750:Rabeprazole; D055502:Secondary Prevention; D013988:Ticlopidine / Q000031:analogs & derivatives* / Q000494:pharmacology
D053799:2-Pyridinylmethylsulfinylbenzimidazoles; D010975:Platelet Aggregation Inhibitors; D054328:Proton Pump Inhibitors; D064747:Lansoprazole; D064750:Rabeprazole; D000077144:Clopidogrel; D009853:Omeprazole; D013988:Ticlopidine